5th gen glp 1 agonist GLP-1 Agonists: A Comprehensive Overview Mapping the effectiveness and risks
Description
& Sokolowski, C
Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain mostbut not allof their weight loss, according to a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators
Around 13 states currently offer some form of GLP1s coverage for weight loss as of early 2026, and this number is growing
Only one study included in the review used a validated 24-h dietary recall method
81: 161168 [DOI] [PubMed] [Google Scholar] 174.Seino Y, Rasmussen MF, Nishida T, et al
What is a specified' substance or method
